Gift of Life Biologics

What Gift of Life Biologics does

Gift of Life Biologics is a vertically integrated supplier of cellular starting materials for the cell and gene therapy industry, operating as the commercial subsidiary of the Gift of Life Marrow Registry (a non-profit founded in 1995). The company leverages three decades of assets accumulated by its parent, including an international public donor registry of over 550,000 fully characterized allogeneic donors with HLA typing, a wholly owned apheresis collection center (the Adelson Gift of Life Collection Center, the first registry-integrated apheresis center globally), and in-house cell processing and cryopreservation capabilities, all centralized in a 43,560 square foot facility in Boca Raton, Florida staffed by over 135 professionals.

The core product portfolio consists of fresh and cryopreserved leukopaks (including G-CSF mobilized variants), as well as isolated BioBank products such as peripheral blood mononuclear cells (PBMCs), CD34+ hematopoietic stem cells, natural killer (NK) cells, and CD4+/CD8+ T-cells, offered in research-grade (RUO+), GTP-compliant, and GMP tiers. Operations are powered by Cellect, a proprietary supply chain software platform providing custom donor search, end-to-end chain-of-custody tracking, and 24/7 managed logistics with temperature-controlled shipping to over 50 countries.

The company monetizes through a hybrid model: self-serve e-commerce for off-the-shelf cryopreserved BioBank inventory and custom-quote enterprise sales for made-to-order fresh products, primarily serving biopharmaceutical companies and cell/gene therapy developers, with secondary segments in academic research institutions and CDMOs. Pricing is not publicly disclosed; custom quotes are returned within two business days. The company holds multiple accreditations (WMDA, AABB, CLIA, AABB CSM qualification, FDA HCT/P registration, and state tissue/drug distributor licenses in Florida and New York) and is a qualified supplier to Be The Match BioTherapies and an approved apheresis center for the National Marrow Donor Program. Gift of Life Biologics closed a $6 million seed funding round in Q1 2022 led by Three Bridges Private Capital.

Name

Gift of Life Biologics

Legal name

Gift of Life Biologics

Website

https://giftoflifebio.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

51–100 employees

Short description

Gift of Life Biologics supplies cellular starting materials (leukopaks, PBMCs, CD34+, NK, and T-cells) to biopharmaceutical and cell/gene therapy developers through a vertically integrated platform combining a 550,000+ donor registry, apheresis collection, processing, and proprietary Cellect supply chain software.

Ownership category

akta.pro rank

Product category

Cellular Starting Materials

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Blood and Organ Banks (621991), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC)

akta.pro secondary industries

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Cellular starting materials
• Leukopak supply services
• Apheresis collection services
• Cell therapy supply chain
• Biopharmaceutical starting materials

Headquarters

HQ city

Boca Raton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Cellular Starting Materials Sales: Revenue from selling cellular starting materials including leukopaks, peripheral blood mononuclear cells, CD34+ cells, NK cells, T-cells, and custom products to biopharmaceutical companies and cell/gene therapy developers. Products sold as research use only (RUO+), GTP-compliant, or GMP-grade material.
2. BioBank Products: Off-the-shelf cryopreserved cell products available from inventory for immediate purchase and shipment, providing recurring revenue from established product catalog.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Gift of Life Biologics is a vertically integrated supplier of cellular starting materials for the cell and gene therapy industry. It collects, processes, cryopreserves, and distributes fresh and cryopreserved Leukopaks (RUO+ and GTP-compliant), Mobilized Leukopaks, Peripheral Blood Mononuclear Cells, CD34+ stem cells, NK cells, and T-cells sourced from its parent organization's 550,000+ donor registry. Customers include biopharmaceutical companies developing cell, gene, and CAR-T therapies, CDMOs, and academic researchers.

Product overview

Gift of Life Biologics operates as a vertically integrated supplier of cellular starting materials for the biopharmaceutical and cell and gene therapy industry. The product portfolio consists of biological starting materials organized into two main categories: Leukopaks (fresh and cryopreserved, including G-CSF mobilized variants) and a BioBank of isolated cell products (Peripheral Blood Mononuclear Cells, CD34+ stem cells, Natural Killer Cells, and CD4+ CD8+ T-cells). These are complemented by the Cellect proprietary software platform providing custom donor search, supply chain management, and logistics capabilities. Products are available in research grade (RUO+), GTP-compliant, and GMP-grade tiers.

Differentiator

Problem solved

Functional benefit

Brands

• Cellect: Proprietary donor search and cell therapy supply chain software that powers all aspects of cell therapy operations, including order management and traceability.

Products and services

• Leukopaks (RUO+ and GTP)

Quantifiable outcome

• Over 6,648 cell therapy treatments facilitated through the registry
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Gift of Life Marrow RegistrycoreStrategic or Co-development PartnerParent organization providing the donor registry database, 30 years of expertise in recruiting and qualifying volunteer donors, and established infrastructure for delivering marrow and stem cells. Gift of Life Biologics operates as the commercial arm providing starting materials to cell and gene therapy developers.
• Terumo (Spectra Optia)coreTechnology or IntegrationTerumo's Spectra Optia Apheresis System is used at the Adelson Gift of Life Collection Center for collection of HPC-A and MNC-A products. The collection center features seven apheresis stations utilizing Spectra Optia technology.
• Be The Match BioTherapiescoreStrategic or Co-development PartnerContract manufacturer relationship where Gift of Life Biologics serves as a qualified supplier for HPC-A and MNC-A products. This relationship validates the company's quality systems meet industry standards.
• National Marrow Donor Program (NMDP)coreStrategic or Co-development PartnerApproved apheresis center for the National Marrow Donor Program, demonstrating compliance with NMDP standards for stem cell and bone marrow donor operations.
• Private Cold Logistics SpecialistsminorChannel Partner/ Reseller/ DistributorIndustry-leading private cold logistics specialists providing unaccompanied courier and hand courier services. The hand courier network includes over 12,000 professional couriers in over 50 countries for personally accompanied transport of sensitive shipments.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Be The Match BioTherapies: Operated by the National Marrow Donor Program, Be The Match BioTherapies supplies cellular starting materials (HPC-A, MNC-A) to cell therapy developers — directly comparable product offering and customer base. Gift of Life Biologics is also a qualified supplier to Be The Match BioTherapies, making them both partner and competitor.
• AllCells: AllCells is a vertically integrated supplier of primary cells and apheresis products (leukopaks, PBMCs, hematopoietic cells) for cell therapy and research customers. Most direct head-to-head competitor to Gift of Life Biologics in cryopreserved and fresh cellular starting materials.
• Discovery Life Sciences: Discovery Life Sciences supplies human biospecimens including blood, PBMCs, and cellular products to biopharma and academic researchers. Overlapping product portfolio and customer segments in cellular starting materials for research and clinical applications.
• BioIVT: BioIVT supplies biospecimens, including leukopaks, PBMCs, and disease-state samples, to researchers and biopharma. Competes directly with Gift of Life Biologics in the RUO+ and research-grade cellular starting materials market.

Broad incumbents

• HemaCare (Charles River Laboratories): HemaCare, now part of Charles River Laboratories, supplies primary human blood cells, leukapaks, and apheresis-derived products to cell therapy developers and researchers. Comparable starting materials catalog with substantially larger parent backing and global footprint.
• Lonza Cell & Gene Technologies: Lonza provides cell therapy manufacturing services and starting materials across research, clinical, and commercial stages. Competes in adjacent segments (manufacturing services, raw materials) with substantially larger scale and global GMP capacity.
• Charles River Laboratories: Charles River provides cell therapy CDMO services, starting materials (via HemaCare acquisition), and related research products to biopharma. Operates broadly in cell therapy services with overlapping capabilities and customer base.

Emerging players

• CellGenix: CellGenix manufactures GMP-grade raw materials (cytokines, growth factors) and cell processing reagents for cell and gene therapy developers. Adjacent player supplying complementary inputs into the same cell therapy manufacturing workflows Gift of Life Biologics serves.
• Stemcell Technologies: Stemcell Technologies supplies cell isolation products, primary cells, and cell culture media for research and clinical applications. Overlapping customer base in academic and biotech research with differentiated focus on isolation reagents and culture tools.
• iQ Biosciences: iQ Biosciences provides human primary cells, leukopaks, and custom cell isolation services for cell therapy and immunology research. Smaller-scale direct peer with comparable product offering to Gift of Life Biologics' BioBank catalog.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gift of Life Biologics